155 related articles for article (PubMed ID: 37981080)
41. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p.
Gao ZQ; Wang JF; Chen DH; Ma XS; Yang W; Zhe T; Dang XW
Biomed Pharmacother; 2018 Jan; 97():809-817. PubMed ID: 29112934
[TBL] [Abstract][Full Text] [Related]
43. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
45. SNHG11: A New Budding Star in Tumors and Inflammatory Diseases.
Wu Y
Mini Rev Med Chem; 2023; 23(20):1993-2006. PubMed ID: 37165588
[TBL] [Abstract][Full Text] [Related]
46. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis.
Wei G; Lu T; Shen J; Wang J
Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531
[TBL] [Abstract][Full Text] [Related]
47. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
48. Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs.
Chang G; Xie D; Hu J; Wu T; Cao K; Luo X
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270630
[TBL] [Abstract][Full Text] [Related]
49. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.
Sharma GG; Okada Y; Von Hoff D; Goel A
Semin Cancer Biol; 2021 Oct; 75():153-168. PubMed ID: 33049362
[TBL] [Abstract][Full Text] [Related]
50. LncRNAs in pancreatic cancer.
Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
[TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p.
Huang B; Liu C; Wu Q; Zhang J; Min Q; Sheng T; Wang X; Zou Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):828-834. PubMed ID: 27888106
[TBL] [Abstract][Full Text] [Related]
52. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
[TBL] [Abstract][Full Text] [Related]
54. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
Jin KT; Lu ZB; Lv JQ; Zhang JG
RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
[TBL] [Abstract][Full Text] [Related]
55. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer.
Cheng C; Liu D; Liu Z; Li M; Wang Y; Sun B; Kong R; Chen H; Wang G; Li L; Hu J; Li Y; Chen H; Zhao Z; Zhang T; Zhu S; Pan S
Cancer Sci; 2022 Sep; 113(9):2986-3001. PubMed ID: 35534983
[TBL] [Abstract][Full Text] [Related]
56. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNAs and endometrial cancer.
Liu H; Wan J; Chu J
Biomed Pharmacother; 2019 Nov; 119():109396. PubMed ID: 31505425
[TBL] [Abstract][Full Text] [Related]
59. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
60. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]